- Case report
- Open Access
- Open Peer Review
Unilateral endogenous fungal endophthalmitis after esophageal cancer surgery: a case report
© The Author(s). 2018
- Received: 20 November 2017
- Accepted: 10 December 2018
- Published: 18 December 2018
This study reports a case of Unilateral Endogenous Fungal Endophthalmitis After Esophageal Cancer Surgery.
One patient presented with a month-long loss of vision in his left eye, he had surgery for esophageal cancer 2 months earlier. The patient underwent cataract surgery (by phacoemulsification) in the left eye combined with 25-gauge vitrectomy and silicone oil tamponade. The microbiological culture pointed to infection with Candida albicans. At 3-month follow-up, the unaided visual acuity of left eye was 0.02 and corrected visual acuity was 0.2. In addition, there was no recurrence of the endophthalmitis within 1 year of the surgery.
The early diagnosis of endogenous fungal endophthalmitis is difficult, and the disease is very likely to be misdiagnosed as uveitis. It is therefore critical to improve awareness of this condition and to reduce the incidence of its misdiagnosis.
- Postcancer surgery
- Case report
Endogenous endophthalmitis is an infection due to fungi or bacteria that enter the eye through the circulating blood, causing inflammation of intraocular tissues such as the vitreous body and retina. Endogenous endophthalmitis accounts for 2 to 15% of all cases of endophthalmitis [1, 2]. Herein we report one cases of Unilateral Endogenous Fungal Endophthalmitis After Esophageal Cancer Surgery.
Endogenous fungal endophthalmitis is characterized by its low incidence, insidious onset, and high degree of destructiveness, which can lead to atrophy of the eyeball and permanent visual impairment. The risk factors for endogenous fungal endophthalmitis include systemic diseases (e.g., diabetes, liver cirrhosis, malignant tumors, and acquired immunodeficiency syndrome) and/or the presence of an infectious lesion (e.g., liver abscess, meningitis, and lung abscess) [2–4]. Among all cases of endogenous fungal endophthalmitis, endogenous C. albicans endophthalmitis is the most common type, representing 75 to 80% of the cases; Aspergillus is the second most common causative organism [5–7]. The effective treatment of endogenous fungal endophthalmitis rests on the combination of timely vitrectomy and systemic antifungal therapy. In addition, silicone oil has antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and C. albicans [8, 9]. The patient reported here, who suffered from endogenous C. albicans endophthalmitis, had the risk factor of a malignant tumor. Before we operated on his eye, the endophthalmitis had progressed to stage III (vitreous opacity), and the eye could only perceive light. Following timely surgery and antifungal treatment, we were able to restore partial visual function to the affected eye. In general, the early diagnosis of endogenous fungal endophthalmitis is difficult, and the disease is very likely to be misdiagnosed as uveitis. Moreover, with the improper use of steroids or immunosuppressive agents, endogenous fungal endophthalmitis can rapidly progress. In recent years, in the context of the increased use of intravenous drugs and the application of immunosuppressive agents, the incidence of endogenous fungal endophthalmitis has tended to increase. It is therefore critical to improve awareness of this condition and to reduce the incidence of its misdiagnosis.
This study is supported by the Natural Science Foundation of Ningbo City (2017A610237).and by the Projects of medical and health technology development program in Zhejiang province (2017KY619).
Availability of data and materials
The data supporting conclusions of this article are included within this article.
Q.Y. and W.L. were involved with the design of the research. Q.Y. performed the surgery. L.C. and Z.B. assembled and analyzed the data. All of the authors reviewed the data and participated in the writing of the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hong W, Wenbing W, Lin S. Endogenous endophthalmitis from the perspective of the Holistic Integrative Medicine. Chin J Ophthalmol Med. 2015;5(1):1–4.Google Scholar
- Connell PP, O'Neill EC, Fabinyi D, Islam FM, Buttery R, McCombe M, Essex RW, Roufail E, Clark B, Chiu D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral Centre. Eye. 2011;25(1):66–72.View ArticleGoogle Scholar
- Lim HW, Shin JW, Cho HY, Kim HK, Kang SW, Song SJ, Yu HG, Oh JR, Kim JS, Moon SW, et al. Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina. 2014;34(3):592–602.View ArticleGoogle Scholar
- Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A, Durand ML, Miller JW, Husain D. Endogenous Endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm. 2016:26(4):496–503.Google Scholar
- Xuguang S, Jialiang Z. The diagnosis and treatment of candida endophthalmitis. Chin J Infect Chemother. 2011;11(2):112–3.Google Scholar
- Shiying S, Ge Z, Xiaoyan S, Qian W, Bin Y. Etiology and pathogens of fungal endophthalmitis. Chin J Ophthalmol Med. 2014;50(11):808–13.Google Scholar
- Chen KJ, Wu WC, Sun MH, Lai CC, Chao AN. Endogenous fungal endophthalmitis: causative organisms, management strategies, and visual acuity outcomes. Am J Ophthalmol. 2012;154(1):213–4 author reply 214.View ArticleGoogle Scholar
- William A, Spitzer MS, Deuter C, Blumenstock G, Partsch M, Voykov B, Ziemssen F, Bartz-Schmidt KU, Doycheva D. Outcomes of primary Transconjunctival 23-gauge vitrectomy in the diagnosis and treatment of presumed endogenous fungal Endophthalmitis. Ocul Immunol Inflamm. 2016:1–7.Google Scholar
- Birnbaum FA, Gupta G. The role of early vitrectomy in the treatment of fungal endogenous Endophthalmitis. Retin Cases Brief Rep. 2016;10(3):232–5.View ArticleGoogle Scholar